Fundación MEDINA is a Non Profit Research Organization established in 2008 through a public-private alliance between the Regional Government of Andalusia, the pharmaceutical company Merck Sharp & Dohme de España S.A. (MSD), and the University of Granada.

MEDINA’s research team is directly descended from the former Centro de Investigación Básica de España (CIBE), MSD’s Global Drug Discovery Center, one of the longest operating and most successful Natural Products drug discovery programs in the pharmaceutical industry, and traces its roots back through more than 50 years of experience.

MEDINA's team has a collective experience with and unbroken historical ties to successfully marketed drugs (MEFOXIN, PRIMAXIN, MEVACOR and CANCIDAS) and to some of the most important natural products discoveries of recent decades (platensimycin and platencin, moriniafungin,  enfumafungin, parnafungins, lucensimycin, philipimycin, and kibdelomycin among others).

MEDINA leverages this industrial-derived experience, personnel and equipment to position as a Centre of Excellence for research and development in drug discovery and high valued biotechnology products. MEDINA scientists have been attracted from the pharmaceutical, biotech and academic sectors, and they operate as part of a multidisciplinary team with skills in molecular and cell biology, industrial and clinical microbiology, informatics and automation, compound management, analytics and natural products chemistry.

This experience is enriched by the opportunities offered by the Health Sciences Technological Park of Granada to establish collaborations with biotech companies, academic and clinical research groups from the University and the Andalusian Health Institute, a unique research network that favors the possibilities of translational research into the clinic.

MEDINA currently has active research collaborations with international research groups in the academic and the industrial sectors.